https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
It has been well established in the world that lipid disorders promote the development of atherosclerosis and its clinical consequences. This study aimed to assess the impacts of a Persian medicinal (PM) compound on lipid profile. From June 21 to October 21, 2020, a randomized double-blind controlled clinical trial was conducted with 74 dyslipidemic patients, who were randomly divided into two equally populated groups one prescribed with a Persian medicinal herbal compound ( = 37) and a placebo group ( = 37). A Persian he
Like
Comment
Share
